港股異動 | 體育用品股走強 安踏(2020.HK)續創歷史新高 市值超4100億
格隆匯2月16日丨體育用品股走強,安踏(2020.HK)漲超4%續創歷史新高,市值超4100億港元;李寧、特步、滔搏等紛紛上漲。據悉,2020年全年,李寧累漲129.94%,安踏累漲77.65%,滔搏累漲32.57%。今年以來,安踏已累漲近24%,滔搏、中國動向累漲超10%。高盛曾發研報指,雖然新冠病毒個案反彈及在農曆新年前後實施人流管制,或會影響短期運動服飾的銷售,但仍對行業潛在的銷售復甦抱正面態度。隨着運動參與度提高、政府的政策支持及體育用品公司在產品、品牌及渠道的策略提升,相信長期的結構性增長會維持不變。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.